46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

19 trials found

diseases per page:

Showing 1 to 10 of 19 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-005309-35-LV (EUCTR)	04/08/2017	19/05/2017	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm	NULL	Not Recruiting			Female: yes Male: yes	1880	Phase 3	United States;Belarus;Taiwan;Estonia;Turkey;Lithuania;Russian Federation;Colombia;United Kingdom;Cze ...
2	EUCTR2015-005309-35-BG (EUCTR)	22/06/2017	02/05/2017	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 23.1;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm International, LLC.	NULL	Not Recruiting			Female: yes Male: yes	1880	Phase 3	Belarus;United States;Czechia;Taiwan;Estonia;Lithuania;Turkey;Russian Federation;Colombia;United Kin ...
3	EUCTR2015-005309-35-GB (EUCTR)	16/06/2017	09/06/2016	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1880	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Belarus;Taiwan;Estonia;Lithuania;Turkey;Russian Federation;Colombia;United Kingdom;Cze ...
4	EUCTR2015-005309-35-DE (EUCTR)	23/05/2017	24/01/2017	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 23.1;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm International LLC	NULL	Not Recruiting			Female: yes Male: yes	1880	Phase 3	United Kingdom;Czech Republic;Hungary;Mexico;Argentina;Poland;Brazil;Romania;Bulgaria;Germany;Latvia ...
5	EUCTR2015-005309-35-PL (EUCTR)	19/05/2017	17/03/2017	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 23.1;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm International LLC	NULL	Not Recruiting			Female: yes Male: yes	1880	Phase 3	Belarus;United States;Czechia;Estonia;Taiwan;Lithuania;Turkey;Russian Federation;Colombia;United Kin ...
6	EUCTR2015-005307-83-RO (EUCTR)	28/03/2017	22/06/2016	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III St ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 23.1;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm	NULL	Not Recruiting			Female: yes Male: yes	1575	Phase 3	United States;Czechia;Taiwan;Estonia;Lithuania;Russian Federation;Colombia;United Kingdom;Czech Repu ...
7	EUCTR2015-005309-35-HU (EUCTR)	16/03/2017	02/02/2017	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 19.1;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm	NULL	Not Recruiting			Female: yes Male: yes	1880	Phase 3	United States;Belarus;Taiwan;Estonia;Turkey;Lithuania;Russian Federation;Colombia;United Kingdom;Hun ...
8	EUCTR2015-005309-35-CZ (EUCTR)	16/03/2017	31/01/2017	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm International LLC	NULL	Not Recruiting			Female: yes Male: yes	1880	Phase 3	United States;Belarus;Taiwan;Estonia;Turkey;Lithuania;Russian Federation;Colombia;United Kingdom;Cze ...
9	EUCTR2015-005309-35-LT (EUCTR)	06/03/2017	31/01/2017	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 21.0;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm International LLC	NULL	Not Recruiting			Female: yes Male: yes	1880	Phase 3	United States;Belarus;Taiwan;Estonia;Turkey;Lithuania;Russian Federation;Colombia;United Kingdom;Cze ...
10	EUCTR2015-005307-83-LV (EUCTR)	03/03/2017	16/03/2016	Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheuma ...	A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III St ...	Moderately to Severely Active Rheumatoid Arthritis MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Olokizumab Product Code: (CDP6038; L04041) INN or Proposed INN: Olokizumab Other descript ...	R-Pharm	NULL	Not Recruiting			Female: yes Male: yes	1575	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Taiwan;Estonia;Lithuania;Russian Federation;Colombia;United Kingdom;Czech Republic;Hun ...

First Previous1 2Next Last